×
Hero Background

Hyperhidrosis Treatment Companies

ID: MRFR/Pharma/7003-HCR
140 Pages
Rahul Gotadki
October 2025

Hyperhidrosis treatment companies specialize in the development and provision of products or services aimed at managing or alleviating excessive sweating, a condition known as hyperhidrosis. These companies may offer medical devices, pharmaceuticals, or other interventions to address the symptoms of hyperhidrosis. 

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Hyperhidrosis Treatment Market

Hyperhidrosis Treatment Key Companies

 

Latest Hyperhidrosis Treatment Companies Update


Revance Therapeutics, a pioneer in the field, receives FDA approval for Qbrexza (glycopyrronium) cloth wipes, the first once-daily topical treatment for excessive underarm sweating in adults. This non-invasive option offers a convenient and effective solution for many patients.


Dermira, another key player, announces positive results from a Phase 3 trial of DRM04, a topical cream for axillary hyperhidrosis. This new option, if approved, could expand treatment options for patients seeking non-surgical solutions.


Botanix Pharmaceuticals expects to resubmit its New Drug Application (NDA) for BTXA, a topical botulinum toxin A treatment for underarm hyperhidrosis, in the first quarter of 2024. This potential market entrant could offer a longer-lasting alternative to existing topical options.


List of Hyperhidrosis Treatment Key Companies in the Market




  • Brickell Biotech Inc. (US)




  • Allergan PLC (Ireland)




  • Cynosure (US)




  • Dermira Inc. (US)




  • Dermadry Laboratories inc. (Canada)




  • GlaxoSmithKline PLC (UK)




  • Sesderma (Spain)




  • Miramar Labs Inc. (US)




  • Ulthera Inc. (US)